Eugia Steriles Profile
Key Indicators
- Authorised Capital ₹ 50.00 Cr
as on 05-11-2024
- Paid Up Capital ₹ 44.25 Cr
as on 05-11-2024
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2023)
- Profit -66.07%
(FY 2023)
- Ebitda -71.81%
(FY 2023)
- Net Worth -0.83%
(FY 2023)
- Total Assets 192.99%
(FY 2023)
About Eugia Steriles
The Corporate was formerly known as Auro Cure Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 50.00 Cr and a paid-up capital of Rs 44.25 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Eugia Steriles Private Limited India are Kalpana Kanduri as CFO and Sriharsha Poduri as Company Secretary. Madan Mettu, Sivakumaran Meenakshisunderam, and Santhanam Subramanian serve as directors at the Company.
- CIN/LLPIN
U24239TG2020PTC141428
- Company No.
141428
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Jul 2020
- Date of AGM
22 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Eugia Steriles?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kalpana Kanduri  | CFO | Current | |
| Sriharsha Poduri | Company Secretary | 05-Jul-2023 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Madan Mettu | Director | 05-Jul-2020 | Current |
| Sivakumaran Meenakshisunderam | Director | 05-Jul-2020 | Current |
| Santhanam Subramanian | Director | 09-Feb-2023 | Current |
Financial Performance and Corporate Structure Insights of Eugia Steriles.
Eugia Steriles Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 66.07% decrease in profit. The company's net worth dipped by a decrease of 0.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eugia Steriles?
In 2023, Eugia Steriles had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Eugia Pharma Specialities LimitedActive 11 years 8 monthsMadan Mettu and Santhanam Subramanian are mutual person
- Curateq Biologics Private LimitedActive 4 years 7 months
Madan Mettu and Sivakumaran Meenakshisunderam are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Eugia Steriles?
Eugia Steriles has a workforce of 245 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eugia Steriles, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eugia Steriles's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
